Citation: Mg. Lee et al., Costunolide induces apoptosis by ROS-mediated mitochondrial permeability transition and cytochrome C release, BIOL PHAR B, 24(3), 2001, pp. 303-306
Citation: Ds. Byun et al., Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma, CANCER RES, 61(19), 2001, pp. 7034-7038
Authors:
Kang, MJ
Park, BJ
Byun, DS
Park, JI
Kim, HJ
Park, JH
Chi, SG
Citation: Mj. Kang et al., Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma, CLIN CANC R, 6(5), 2000, pp. 1767-1771
Authors:
Bae, DK
Park, YK
Chi, SG
Lee, CW
Unni, KK
Citation: Dk. Bae et al., Mutational alterations of the p16(CDKN2A) tumor suppressor gene have low incidence in mesenchymal chondrosarcoma, ONCOL RES, 12(1), 2000, pp. 5-10
Authors:
Park, BJ
Park, JI
Byun, DS
Park, JH
Chi, SG
Citation: Bj. Park et al., Mitogenic conversion of transforming growth factor-beta 1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer, CANCER RES, 60(11), 2000, pp. 3031-3038
Authors:
Park, YK
Chi, SG
Kim, YW
Park, HR
Unni, KK
Citation: Yk. Park et al., Mutational alteration of the p16(CDKN2a) tumor suppressor gene is infrequent in Ewing's sarcoma, ONCOL REP, 6(6), 1999, pp. 1261-1266
Authors:
Chi, SG
Chang, SG
Lee, SJ
Lee, CH
Il Kim, J
Park, JH
Citation: Sg. Chi et al., Elevated and biallelic expression of p73 is associated with progression ofhuman bladder cancer, CANCER RES, 59(12), 1999, pp. 2791-2793
Authors:
Meyers, FJ
Gumerlock, PH
Chi, SG
Borchers, H
Deitch, AD
White, RWD
Citation: Fj. Meyers et al., Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors, CANCER, 83(12), 1998, pp. 2534-2539